WG5. Biomarkers of Metastatic ILC
Leadership
Amanda Fitzpatrick
KCL and GUY'S
Christine Desmedt
KU LEUVEN
Sylvia Knoll
PA (AUSTRIA)
Andrea Lener
PA (ISLE OF MAN)
Participants
| Andrea | Lener | ELBCA |
| Anya | Nicholas | ICR |
| Caroline | Malhaire | Institut Curie |
| Clare | Isacke | ICR |
| Esme | Bullock | ICR |
| Georgios | Skiadas | ICR |
| Hannah | Wen | MSK |
| Marco Antonio | Rioja Vega | INEN |
| Maria Gabriela | Raso | MD Anderson Cancer Center |
| Meritxell | Bellet | Vall d’ Hebron University Hospital and VHIO |
| Patrick | Derksen | UMC Utrecht |
| Rachael | Natrajan | ICR |
| Renee | Flaherty | ICR |
| Sankari | Nagarajan | University of Manchester |
| Santiago | Madera | ICR |
| Sonia | Pernas | Catalan Institute of Oncology |
| Susan | Fineberg | Montefiore Medical Center |
| Syed | Haider | ICR |
| Thurkaa | Shanmugalingam | King’s College |
Past and Future meetings
TBD
Info here.
TBD
Info here.
Activities
The Biomarkers of Metastatic ILC working group has been newly formed in 2025. Come back later for more content.